The main clinical signs and symptoms reported in this outbreak include fever, difficulty breathing, and chest radiographs indicating bilateral lung infiltration. As of 27 January 2020, large-scale human-to-human transmission has been confirmed in Wuhan city, but also in China and some other locations internationally. Not enough is known about the epidemiology of 2019-nCoV to make definitive conclusions about the full clinical characteristics of the disease, the intensity of human-to-human transmission, and the original source of the outbreak.
International travelers: Take general precautions
Coronaviruses are a large family of respiratory viruses that can cause diseases ranging from the common cold to Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). In case of signs of acute respiratory illness symptoms before or after travel, travelers are encouraged to seek medical care and share travel history with their healthcare provider.
Public health officials should provide information to travelers through health practitioners, travel health clinics, travel agencies, convention operators, and points of entry to reduce the general risk of acute respiratory infections. Novel Coronavirus (2019-nCoV) advice to the public published on the WHO website includes standard recommendations of the WHO for the general public to reduce the risk of a range of diseases and protect yourself and others from getting sick. So, be healthy while traveling. .
WHO technical guidance on monitoring and case definition, laboratory guidance, clinical management for suspected novel coronaviruses, suspected novel coronoviruses, infection prevention and control, risk communication, disease commodity packages, and reducing transmission from animals to humans At-home care is available.
International Traffic Related Health Measures
The current outbreak originated in Wuhan city, which is a major domestic and international transport hub. Given the movements of large populations, and human-to-human transmission, it is not unexpected that new confirmed cases will continue to appear in other regions and countries. With currently available information for novel coronaviruses, WHO advises that measures to limit the risk of disease export or import should be implemented, without unnecessary restrictions on international traffic.
Exit screening advice in countries or regions with ongoing broadcast of novel coronovirus 2019-nCoV (currently People's Republic of China)
Conduct exit screening at international airports and seaports in the affected areas, aimed at early detection of symptomatic travelers for further evaluation and treatment, and thereby preventing the export of the disease. Reducing interference with international traffic;
Exit screening to check for signs and symptoms (fever, cough above 38 degrees), interviewing travelers with respiratory infection symptoms in relation to the potential risk of high-risk contacts, excluding affected areas or presuming animal source, coming forward Includes directing passengers. Medical examination, after testing for 2019-nCoV, and taking into account confirmed cases under isolation and treatment;
Encourage screening at domestic airports, railway stations and long distance bus stations as required;
Passengers who had contact with confirmed cases or direct contact with a potential source of infection should be placed under medical observation. High-risk contacts should avoid travel for the incubation period (up to 14 days);
Implementing a health information campaign to reduce the general risk of acute respiratory infections and raise awareness about the measures needed, a traveler should develop signs and symptoms of infection with 2019-nCoV and how they can get help .
Advice for admissions screening in countries / regions without broadcasting of novel / coronovirus 2019-nCoV who choose to do admissions screening
Evidence from previous outbreaks suggests that the effectiveness of admission screening is uncertain, but it supports a risk communication strategy to reduce the general risk of acute respiratory infection to travelers from affected countries / regions and if they seek medical attention early. can do. Develop symptoms compatible with infection.
During the current outbreak with the novel coronovirus 2019-nCoV, a number of exported cases were detected through entry screening implemented by some countries. Symptomatic cases can be detected through a temperature check at the point of entry, for which medical tests and laboratory tests will be performed to confirm. Passengers who check the temperature to detect potentially suspicious cases at the point of entry may be likely to conceal a fever during a trip or have a fever. A focused app
International travelers: Take general precautions
Coronaviruses are a large family of respiratory viruses that can cause diseases ranging from the common cold to Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). In case of signs of acute respiratory illness symptoms before or after travel, travelers are encouraged to seek medical care and share travel history with their healthcare provider.
Public health officials should provide information to travelers through health practitioners, travel health clinics, travel agencies, convention operators, and points of entry to reduce the general risk of acute respiratory infections. Novel Coronavirus (2019-nCoV) advice to the public published on the WHO website includes standard recommendations of the WHO for the general public to reduce the risk of a range of diseases and protect yourself and others from getting sick. So, be healthy while traveling. .
WHO technical guidance on monitoring and case definition, laboratory guidance, clinical management for suspected novel coronaviruses, suspected novel coronoviruses, infection prevention and control, risk communication, disease commodity packages, and reducing transmission from animals to humans At-home care is available.
International Traffic Related Health Measures
The current outbreak originated in Wuhan city, which is a major domestic and international transport hub. Given the movements of large populations, and human-to-human transmission, it is not unexpected that new confirmed cases will continue to appear in other regions and countries. With currently available information for novel coronaviruses, WHO advises that measures to limit the risk of disease export or import should be implemented, without unnecessary restrictions on international traffic.
Exit screening advice in countries or regions with ongoing broadcast of novel coronovirus 2019-nCoV (currently People's Republic of China)
Conduct exit screening at international airports and seaports in the affected areas, aimed at early detection of symptomatic travelers for further evaluation and treatment, and thereby preventing the export of the disease. Reducing interference with international traffic;
Exit screening to check for signs and symptoms (fever, cough above 38 degrees), interviewing travelers with respiratory infection symptoms in relation to the potential risk of high-risk contacts, excluding affected areas or presuming animal source, coming forward Includes directing passengers. Medical examination, after testing for 2019-nCoV, and taking into account confirmed cases under isolation and treatment;
Encourage screening at domestic airports, railway stations and long distance bus stations as required;
Passengers who had contact with confirmed cases or direct contact with a potential source of infection should be placed under medical observation. High-risk contacts should avoid travel for the incubation period (up to 14 days);
Implementing a health information campaign to reduce the general risk of acute respiratory infections and raise awareness about the measures needed, a traveler should develop signs and symptoms of infection with 2019-nCoV and how they can get help .
Advice for admissions screening in countries / regions without broadcasting of novel / coronovirus 2019-nCoV who choose to do admissions screening
Evidence from previous outbreaks suggests that the effectiveness of admission screening is uncertain, but it supports a risk communication strategy to reduce the general risk of acute respiratory infection to travelers from affected countries / regions and if they seek medical attention early. can do. Develop symptoms compatible with infection.
During the current outbreak with the novel coronovirus 2019-nCoV, a number of exported cases were detected through entry screening implemented by some countries. Symptomatic cases can be detected through a temperature check at the point of entry, for which medical tests and laboratory tests will be performed to confirm. Passengers who check the temperature to detect potentially suspicious cases at the point of entry may be likely to conceal a fever during a trip or have a fever. A focused app
WATCH MOOR DETAILS TO GO NEXT POST-
No comments:
Post a Comment